ArticleBMC oral health2025
Success rate of inferior alveolar nerve block in diabetic patients with symptomatic irreversible pulpitis: a prospective study.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe global prevalence of Diabetes Mellitus is steadily increasing, leading to a larger diabetic population undergoing root canal treatment (RCT). However, clinical studies assessing anesthetic success in diabetic patients are lacking. In diabetic patients, local anesthetic success may be affected owing to neurovasular changes in dental pulps. This study is intended to establish baseline data regarding local anesthetic success in the diabetic population undergoing RCT. The study's main purpose was to assess the success rate of Inferior Alveolar Nerve Block (IANB) in type 2 diabetic patients during RCT of mandibular molars with symptomatic irreversible pulpitis (SIP).
methodsSixty-five adult patients diagnosed with SIP in mandibular molars were divided into 2 groups according to their glycated hemoglobin (HbA1c) levels; control group (n = 31, HbA1c < 5.7) and diabetic group (n = 34, HbA1c levels > 6.5). After administering IANB and achieving lip numbness, endodontic access was initiated. Pain was recorded during endodontic procedure using Heft Parker visual analogue scale. Anesthetic success was defined as no or mild pain [score 0-54 mm] throughout endodontic procedure. Chi square test and Mann Whitney U tests were used for statistical analysis.
resultsPatients in the diabetic group exhibited significantly higher anesthetic success (94%) as compared to non-diabetic group (74%) (P = 0.016). Patients in the control group were significantly younger than the diabetic group (P < 0.001). Logistic regression revealed that tooth number was significantly associated with anesthetic success while age and gender had no significant influence on anesthetic success.
conclusionsWithin the study limitations, IANB appeared more successful in diabetic patients compared to non-diabetics during RCT of mandibular molars with SIP. Studying local anesthetic success in diabetics is vital for enhancing patient comfort, safety and optimizing outcomes during RCT.
trial registrationThe clinical trial was registered on 24th September 2021 and registration no. is CTRI/2021/09/036813.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.